文献速递关节外科创伤骨科

脂质体布比卡因与髂筋膜间隙阻滞在全髋关节置换术后疼痛控制中的前瞻性随机试验比较

A Prospective, Randomized Trial Comparing Liposomal Bupivacaine vs Fascia Iliaca Compartment Block for Postoperative Pain Control in Total Hip Arthroplasty.
PubMed 文献 · J Arthroplasty · 2017-02-16

一项前瞻性随机对照研究纳入79例择期全髋关节置换术患者,40例接受脂质体布比卡因、39例接受髂筋膜间隙阻滞(FICB),并回顾性分析28例对照。与回顾性对照组相比,脂质体布比卡因组和FICB组的疼痛强度和住院时间均显著降低;仅FICB组的总阿片类药物消耗量较对照组显著降低。

要点

  • 脂质体布比卡因组与FICB组较回顾性对照组疼痛强度显著降低(P = .019)。
  • 脂质体布比卡因组与FICB组较回顾性对照组住院时间显著缩短(P = .041)。
  • 仅FICB组较回顾性对照组总阿片类药物消耗量显著降低(P = .028)。

核心结论

  • 接受择期全髋关节置换术的患者,采用包含脂质体布比卡因或FICB的多模式镇痛方案,总体疼痛强度降低且住院时间缩短。
  • 接受FICB的患者总阿片类药物消耗量低于对照组。

研究设计与样本

  • 前瞻性随机对照研究,纳入2015年6月至2016年2月间接受择期全髋关节置换术的79例患者,其中40例接受脂质体布比卡因、39例接受FICB。
  • 另回顾性调取2015年5月至2015年12月间接受择期全髋关节置换术的28例患者的病历作为对照。
  • 主要结局为视觉模拟量表疼痛评分,次要结局为住院时间和总阿片类药物消耗量;使用SPSS 22版进行单因素方差分析(含对比)和Mood中位数检验。

主要发现

  • 与回顾性对照组相比,脂质体布比卡因组和FICB组的疼痛强度均显著降低(P = .019)。
  • 与回顾性对照组相比,脂质体布比卡因组和FICB组的住院时间均显著缩短(P = .041)。
  • 仅FICB组较回顾性对照组总阿片类药物消耗量显著降低(P = .028)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Increasing demand for total hip arthroplasty (THA) in a climate of increasing focus on clinical outcomes, patient satisfaction, and cost has created a need for better acute postoperative pain control for patients. An ideal pain control method would have few side effects, decreased opioid consumption, improved pain control, early ambulation, and decreased hospital length of stay (LOS). METHODS: We performed a prospective randomized, controlled study involving 79 patients undergoing elective THA between June 2015 and February 2016. Forty patients received liposomal bupivacaine and 39 patients received a fascia iliaca compartment block (FICB). In addition, the medical records of 28 patients who underwent elective THA between May 2015 and December 2015 were retrospectively examined. The primary outcome was visual analog scale pain scores and the secondary outcomes were LOS and total opioid consumption. SPSS, version 22, was used to run 1-way analysis of variance with contrast and Mood's median test on the data. RESULTS: There were statistically significant decreases in pain intensity (P = .019) and LOS (P = .041) in both the liposomal bupivacaine group and the FICB group compared with those in the retrospective control group. In addition, only the FICB group showed statistically significant decreased total opioid consumption compared with that in the retrospective group (P = .028). CONCLUSION: Patients undergoing elective THA have decreased overall pain intensity and a shorter LOS with multimodal pain management regimen that includes either liposomal bupivacaine or FICB. Patients who received FICB required less overall total opioids than the control group.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. McGraw-Tatum MA, Groover MT, George NE, et al. A Prospective, Randomized Trial Comparing Liposomal Bupivacaine vs Fascia Iliaca Compartment Block for Postoperative Pain Control in Total Hip Arthroplasty. J Arthroplasty. 2017. PMID: 28318860. doi:10.1016/j.arth.2017.02.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。